Skip to main content
Clinical Trials/IRCT2016060314372N8
IRCT2016060314372N8
Completed
Phase 2

The evaluation of the effect of dexmedetomidine added to local infiltration of bupivacaine on post-operative pain of pediatric inguinal herniorraphy.

Vice Chancellor for Research, Shiraz University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Inguinal hernia.
Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients between the range of 6 months to 6 years old; (ASA I); patients who have surgery for unilateral inguinal hernia.
  • Exclusion criteria:
  • A history of bleeding disorders, allergies to Dexmedetomidine and bupivacaine; developmental delay; upper respiratory tract infection, congenital heart disease, liver and kidney failure, neurological disease, mental retardation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials